Related Experiment Video
Updated: May 28, 2026

06:30
Optimizing Tubulin Yield from Porcine Brain Tissue
Published on: October 11, 2024
Tubulin-based structure-affinity relationships for antimitotic Vinca alkaloids
Claire Coderch1, Antonio Morreale, Federico Gago
1Departmento de Farmacologia, Universidad de Alcala, Madrid, Spain.
Anti-Cancer Agents in Medicinal Chemistry
|November 3, 2011
Summary
Vinca alkaloids disrupt microtubule assembly in cancer cells. Molecular modeling reveals how these drugs bind to tubulin, explaining differences in their effectiveness and guiding the development of new anticancer therapies.
Area of Science:
- Pharmacology
- Molecular Biology
- Biophysics
Background:
- Vinca alkaloids are crucial anticancer drugs derived from the Madagascar periwinkle.
- These compounds disrupt microtubule dynamics by interfering with α,β-tubulin heterodimer assembly.
- Previous studies characterized binding energies and identified vinblastine's binding site at the tubulin dimer interface.
Purpose of the Study:
- To comparatively analyze the three-dimensional complexes of four Vinca alkaloids with a β1α2-tubulin interface.
- To rationalize the binding affinity differences among vinblastine, vincristine, vinorelbine, and vinflunine.
- To elucidate the binding determinants and structure-activity relationships of these anticancer agents.
Main Methods:
- Utilized molecular modeling and simulation techniques.
- Built and refined three-dimensional complexes of Vinca alkaloids with tubulin.
- Performed comparative analysis in explicit water to assess binding affinities.
Main Results:
- Generated detailed structural and energetic insights into Vinca alkaloid-tubulin interactions.
- Identified key binding determinants responsible for differential drug efficacy.
- Provided a molecular basis for understanding the structure-activity relationships of these anticancer drugs.
Conclusions:
- The study provides a deeper understanding of how Vinca alkaloids interact with tubulin at a molecular level.
- These findings can inform the design of novel Vinca alkaloid derivatives with improved anticancer activity.
- The research contributes to the rational development of more effective cancer chemotherapeutics.
Related Concept Videos
Drugs that Destabilize Microtubules
Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
Drugs that Stabilize Microtubules
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
Destabilization of Microtubules
The destabilization of microtubules can occur during different stages of the microtubule lifecycle, such as nucleation or elongation. It can take place at either end of the microtubule or in the microtubule lattices as a whole. The lifespan of individual microtubules within a cell varies according to the cell type and stage of the cell cycle. During interphase, the lifespan of the microtubule is about 30 minutes, while during cell division, it is about 15 minutes. In axonal microtubules of...
Microtubule Formation
Microtubules are dynamic structures that undergo continuous assembly and disassembly. They originate from specialized multi-protein complexes known as microtubule organizing centers or MTOCs. Within the MTOC, the point of origin of the microtubule is known as the minus end, while the end radiating outward is the plus end. Microtubules serve two primary functions — the organization of spindle complexes to separate sister chromatids during mitotic or meiotic cell division and the formation of...
Antifungal Agents
Amphotericin B is a broad-spectrum antifungal agent that exploits structural differences between fungal and mammalian cell membranes. Its amphipathic structure—featuring a hydrophobic polyene-lactone ring and a hydrophilic region containing mycosamine and carboxylic acid groups—enables selective binding to ergosterol, a sterol predominantly found in fungal plasma membranes. This selective interaction underlies the drug’s antifungal activity, although weak binding to cholesterol contributes to...
Structure-Activity Relationships and Drug Design
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence its...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence its...
